175 related articles for article (PubMed ID: 11580150)
1. Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.
Forns X; Ampurdanès S; Sanchez-Tapias JM; Guilera M; Sans M; Sánchez-Fueyo A; Quintó L; Joya P; Bruguera M; Rodés J
J Hepatol; 2001 Aug; 35(2):265-71. PubMed ID: 11580150
[TBL] [Abstract][Full Text] [Related]
2. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.
Giannini E; Risso D; Botta F; Chiarbonello B; Fasoli A; Malfatti F; Romagnoli P; Testa E; Ceppa P; Testa R
Arch Intern Med; 2003 Jan; 163(2):218-24. PubMed ID: 12546613
[TBL] [Abstract][Full Text] [Related]
3. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?
Park GJ; Lin BP; Ngu MC; Jones DB; Katelaris PH
J Gastroenterol Hepatol; 2000 Apr; 15(4):386-90. PubMed ID: 10824882
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study.
Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
Intern Med J; 2015 Jan; 45(1):48-54. PubMed ID: 25371273
[TBL] [Abstract][Full Text] [Related]
5. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
Sheth SG; Flamm SL; Gordon FD; Chopra S
Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
7. AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.
Reedy DW; Loo AT; Levine RA
Dig Dis Sci; 1998 Sep; 43(9):2156-9. PubMed ID: 9753286
[TBL] [Abstract][Full Text] [Related]
8. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
Carrión JA; Fernández-Varo G; Bruguera M; García-Pagán JC; García-Valdecasas JC; Pérez-Del-Pulgar S; Forns X; Jiménez W; Navasa M
Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
[TBL] [Abstract][Full Text] [Related]
9. Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.
Ghany MG; Kim HY; Stoddard A; Wright EC; Seeff LB; Lok AS;
Hepatology; 2011 Nov; 54(5):1527-37. PubMed ID: 22045670
[TBL] [Abstract][Full Text] [Related]
10. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
[TBL] [Abstract][Full Text] [Related]
11. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Leone N; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
[TBL] [Abstract][Full Text] [Related]
12. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis.
Kim SU; Oh HJ; Wanless IR; Lee S; Han KH; Park YN
J Hepatol; 2012 Sep; 57(3):556-63. PubMed ID: 22617153
[TBL] [Abstract][Full Text] [Related]
13. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
Imperiale TF; Said AT; Cummings OW; Born LJ
Am J Gastroenterol; 2000 Sep; 95(9):2328-32. PubMed ID: 11007237
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
[TBL] [Abstract][Full Text] [Related]
15. Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients.
Arabul M; Aslan F; Alper E; Akpinar Z; Çelık M; Kandemır A; Vatansever S; Ünsal B
Turk J Gastroenterol; 2012; 23(5):538-45. PubMed ID: 23161299
[TBL] [Abstract][Full Text] [Related]
16. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients.
Khan KN; Yatsuhashi H
Alcohol Alcohol; 2000; 35(3):286-95. PubMed ID: 10869250
[TBL] [Abstract][Full Text] [Related]
17. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
18. High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis.
Miyakawa K; Tarao K; Ohshige K; Morinaga S; Ohkawa S; Okamoto N; Shibuya A; Adachi S; Miura Y; Fujiyama S; Miyase S; Tomita K
Scand J Gastroenterol; 2009; 44(11):1340-8. PubMed ID: 19891585
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A; Abdou A; El-Neanaey WA; Diab I
Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
[TBL] [Abstract][Full Text] [Related]
20. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients.
Planas R; Ballesté B; Alvarez MA; Rivera M; Montoliu S; Galeras JA; Santos J; Coll S; Morillas RM; Solà R
J Hepatol; 2004 May; 40(5):823-30. PubMed ID: 15094231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
